11th Circ. Won't Revive Chinese Pharma Class Action Claims
The Eleventh Circuit on Wednesday upheld a lower court's dismissal of claims against the former chief financial officer of Chinese drugmaker Jiangbo Pharmaceuticals Inc. and a former auditing firm for the...To view the full article, register now.
Already a subscriber? Click here to view full article